服务热线
021-60498804
| Cat. Number | 066094824256871 |
||||||||||||||||||||
| Chemical Name | FAAH Inhibitor Screening Assay Kit |
||||||||||||||||||||
| References |
Background ReadingStella, N., Schweitzer, P., and Piomelli, D. A second endogenous cannabinoid that modulates long- Rodríguez De Fonseca, F., Del Arco, I., Bermudez-Silva, F., et al. The endocannabinoid system: Physiology and pharmacology. Alcohol Alcohol 40(1) 2-14 (2005). Kondo, S., Kondo, H., Nakane, S., et al. 2- Lambert, D.M., and Fowler, C.J. The endocannabinoid system: Drug targets, lead compounds, and potential therapeutic applications. J Med Chem 48(16) 5059-5087 (2005). Boger, D.L., Sato, H., Lerner, A.E., et al. Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci USA 97 5044-5049 (2000). Sugiura, T., Kodaka, T., Nakane, S., et al. Evidence that the cannabinoid CB1 receptor is a 2- Dinh, T.P., Carpenter, D., Leslie, F.M., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16) 10819-10824 (2002). Show all 7 Hide all but first 3
Description
The endocannabinoid system is a ubiquitous lipid signaling system involved in various regulatory functions throughout the body. The primary endocannabinoids, arachidonoylethanolamide (AEA) and 2-
|
||||||||||||||||||||
Copyright © 2022 上海惠诚生物科技有限公司
沪ICP备2021037845号-6
